Get started
Author

Alvin Estilo

Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
2020 · Vicente E. Torres, Arlene B. Chapman, et al. · Clinical Journal of the American Society of Nephrology · 44
PDF
Clinical Pattern of Tolvaptan-Associated Liver Injury in Trial Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD): An Analysis of Pivotal Clinical Trials
2022 · David H. Alpers, James H. Lewis, et al. · American Journal of Kidney Diseases · 42
Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
2021 · Juliana Hey-Hadavi, Daniel Seekins, et al. · Drug Safety · 29
Evaluating the impact of a Risk Evaluation and Mitigation Strategy with tolvaptan to monitor liver safety in patients with autosomal dominant polycystic kidney disease
2022 · Alvin Estilo, LaRee Tracy, et al. · Clinical Kidney Journal · 20
PDF
Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study
2021 · Alvin Estilo, Linda McCormick, et al. · Advances in Therapy · 20
PDF
Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial
2024 · Saloni Behl, Mary Slomkowski, et al. · Journal of Alzheimer s Disease · 17
A Post Hoc Analysis of Statin Use in Tolvaptan Autosomal Dominant Polycystic Kidney Disease Pivotal Trials
2020 · Susan E. Shoaf, John Ouyang, et al. · Clinical Journal of the American Society of Nephrology · 14
Safety and Tolerability of Brexpiprazole in Participants with Agitation Associated with Dementia due to Alzheimer’s Disease: Pooled Analysis of Three Randomized Trials and an Extension Trial
2025 · Alpesh Shah, Alvin Estilo, et al. · CNS Drugs · 8
PDF
Industry Review of Best Practices for Risk Management of Drug-Induced Liver Injury from Development to Real-World Use
2023 · Loreta Marquez, Ritu Raheja, et al. · Drug Safety · 6
Using an Automated Algorithm to Identify Potential Drug-Induced Liver Injury Cases in a Pharmacovigilance Database
2021 · Liliam Pineda Salgado, Ritu Gupta, et al. · Advances in Therapy · 3
PDF
Efficacy and Safety of Brexpiprazole in Patients with Agitation Associated with Dementia Due to Alzheimer's Disease Analyzed by Presence or Absence of Baseline Psychosis: A Pooled Analysis
2024 · Saloni Behl, Alpesh Shah, et al. · American Journal of Geriatric Psychiatry · 1
P170: Safety and Tolerability of Brexpiprazole for the Treatment of Agitation in Alzheimer’s Dementia: Pooled Results From Three Phase III Trials
2023 · Anja Farovik, Maia Miguelez, et al. · International Psychogeriatrics
PDF
Early Real-World Descriptive Findings on Tolvaptan-Treated Patients with Autosomal Dominant Polycystic Kidney Disease in the United States
2020 · Myrlene Sanon, Sunning Tao, et al. · Journal of the American Society of Nephrology
Works count: 13
Citation count: 204
H-index: 8
I10-index: 7
Year
Topic
Type